Activation of calpain in cultured neurons overexpressing Alzheimer amyloid precursor protein.

[1]  T. Hara,et al.  Cell death induced by a caspase-cleaved transmembrane fragment of the Alzheimer amyloid precursor protein , 2002, Cell Death and Differentiation.

[2]  P. Nicotera,et al.  Calpain inhibitors prevent nitric oxide-triggered excitotoxic apoptosis , 2001, Neuroreport.

[3]  B. Pike,et al.  Concurrent Assessment of Calpain and Caspase-3 Activation after Oxygen–Glucose Deprivation in Primary Septo-Hippocampal Cultures , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  Changlian Zhu,et al.  Synergistic Activation of Caspase-3 by m-Calpain after Neonatal Hypoxia-Ischemia , 2001, The Journal of Biological Chemistry.

[5]  R. Neve,et al.  Alzheimer’s disease: a dysfunction of the amyloid precursor protein 1 1 Published on the World Wide Web on 11 September 2000. , 2000, Brain Research.

[6]  R. Hata,et al.  Caspase-3 activation and inflammatory responses in rat hippocampus inoculated with a recombinant adenovirus expressing the Alzheimer amyloid precursor protein. , 2000, Brain research. Molecular brain research.

[7]  Junying Yuan,et al.  Cross-Talk between Two Cysteine Protease Families , 2000, The Journal of cell biology.

[8]  Y. Suh,et al.  Carboxyl‐terminal fragment of Alzheimer's APP destabilizes calcium homeostasis and renders neuronal cells vulnerable to excitotoxicity , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  Peng Li,et al.  Direct Cleavage by the Calcium-activated Protease Calpain Can Lead to Inactivation of Caspases* , 2000, The Journal of Biological Chemistry.

[10]  K. Jellinger,et al.  Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. , 1999, The American journal of pathology.

[11]  R. Neve,et al.  Enhanced BK-induced calcium responsiveness in PC12 cells expressing the C100 fragment of the amyloid precursor protein. , 1999, Brain research. Molecular brain research.

[12]  K. Wang,et al.  Procaspase-3 and poly(ADP)ribose polymerase (PARP) are calpain substrates. , 1999, Biochemical and biophysical research communications.

[13]  C. Martínez-A,et al.  Implication of calpain in caspase activation during B cell clonal deletion , 1999, The EMBO journal.

[14]  D. Holtzman,et al.  In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease. , 1999, Journal of neuropathology and experimental neurology.

[15]  K. Yoshikawa,et al.  Activation of Neuronal Caspase-3 by Intracellular Accumulation of Wild-Type Alzheimer Amyloid Precursor Protein , 1999, The Journal of Neuroscience.

[16]  L. Mucke,et al.  Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  E. Newcomb,et al.  Caspase-dependent Activation of Calpain during Drug-induced Apoptosis* , 1999, The Journal of Biological Chemistry.

[18]  J. Shioi,et al.  Overexpression in Neurons of Human Presenilin-1 or a Presenilin-1 Familial Alzheimer Disease Mutant Does Not Enhance Apoptosis , 1998, The Journal of Neuroscience.

[19]  D. Green,et al.  Calpain activation is upstream of caspases in radiation-induced apoptosis , 1998, Cell Death and Differentiation.

[20]  R. Oppenheim,et al.  Increased Production of Amyloid Precursor Protein Provides a Substrate for Caspase-3 in Dying Motoneurons , 1998, The Journal of Neuroscience.

[21]  R. Simon,et al.  Induction of Caspase-3-Like Protease May Mediate Delayed Neuronal Death in the Hippocampus after Transient Cerebral Ischemia , 1998, The Journal of Neuroscience.

[22]  M. Moskowitz,et al.  Activation and Cleavage of Caspase-3 in Apoptosis Induced by Experimental Cerebral Ischemia , 1998, The Journal of Neuroscience.

[23]  H. Okamura,et al.  Degeneration In Vivo of Rat Hippocampal Neurons by Wild-Type Alzheimer Amyloid Precursor Protein Overexpressed by Adenovirus-Mediated Gene Transfer , 1998, The Journal of Neuroscience.

[24]  Hui Zheng,et al.  The β-Amyloid Precursor Protein of Alzheimer’s Disease Enhances Neuron Viability and Modulates Neuronal Polarity , 1997, The Journal of Neuroscience.

[25]  M. Mattson.  Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. , 1997, Physiological reviews.

[26]  R. Nixon,et al.  Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease , 1997, Brain Research.

[27]  A. Ogura,et al.  Glutamate responsiveness enhanced in neurones expressing amyloid precursor protein , 1997, Neuroreport.

[28]  B. Yankner.  Mechanisms of Neuronal Degeneration in Alzheimer's Disease , 1996, Neuron.

[29]  K. Krause,et al.  Overexpression of Calreticulin Increases Intracellular Ca Storage and Decreases Store-operated Ca Influx (*) , 1996, The Journal of Biological Chemistry.

[30]  R. Oppenheim,et al.  Peptide inhibitors of the ice protease family arrest programmed cell death of motoneurons in vivo and in vitro , 1995, Neuron.

[31]  Patrick R. Griffin,et al.  Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis , 1995, Nature.

[32]  H. Sorimachi,et al.  Calpain: new perspectives in molecular diversity and physiological‐pathological involvement , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  Y. Ihara,et al.  Spatial resolution of the primary beta-amyloidogenic process induced in postischemic hippocampus. , 1994, The Journal of biological chemistry.

[34]  K. Suzuki,et al.  Spatial resolution of fodrin proteolysis in postischemic brain. , 1993, The Journal of biological chemistry.

[35]  R. Nixon,et al.  Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[36]  D. Stephenson,et al.  Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat , 1992, Brain Research.

[37]  K. Yoshikawa,et al.  Degeneration in vitro of post-mitotic neurons overexpressing the Alzheimer amyloid protein precursor , 1992, Nature.

[38]  Brian J Cummings,et al.  Aggregation of the amyloid precursor protein within degenerating neurons and dystrophic neurites in alzheimer's disease , 1992, Neuroscience.

[39]  V M Lee,et al.  Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[40]  G. Demartino,et al.  Calcium-activated neutral protease (calpain) system: structure, function, and regulation. , 1991, Physiological reviews.

[41]  E. Masliah,et al.  Accumulation of amyloid precursor fragment in Alzheimer plaques , 1991, Neurobiology of Aging.

[42]  K. Blomgren,et al.  Calpain and calpastatin in normal and Alzheimer-degenerated human brain tissue , 1990, Neurobiology of Aging.

[43]  R. Neve,et al.  The amyloid precursor protein is concentrated in neuronal lysosomes in normal and Alzheimer disease subjects , 1989, Experimental Neurology.

[44]  Carl W. Cotman,et al.  Protease nexin-II, a potent anti-chymotrypsin, shows identity to amyloid β-protein precursor , 1989, Nature.

[45]  P. Andrews.  Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. , 1984, Developmental biology.

[46]  G. Glenner,et al.  Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .

[47]  D. Green,et al.  Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation. , 1999, Blood.

[48]  D. Selkoe,et al.  Normal and abnormal biology of the beta-amyloid precursor protein. , 1994, Annual review of neuroscience.

[49]  K. Suzuki,et al.  Autolytic transition of mu-calpain upon activation as resolved by antibodies distinguishing between the pre- and post-autolysis forms. , 1992, Journal of biochemistry.